November 2023

Neurovalens Receive FDA Clearance for its Modius Sleep Device

Congratulations to portfolio company, Neurovalens, and its CEO, Jason McKeown, on receiving clearance from the FDA on its Modius Sleep device for the treatment of chronic insomnia! A big milestone for the company – well done to the whole Neurovalens team! Article taken from: https://www.massdevice.com/fda-clears-insomnia-treating-device-neurovalens/ Neurovalens announced today that the FDA granted clearance to its Modius Sleep device for treating chronic […]

Neurovalens Receive FDA Clearance for its Modius Sleep Device Read More »

ABOUT US

Clarendon Fund Managers Limited is a venture capital fund manager based in Belfast, authorised and regulated by the Financial Conduct Authority.

Clarendon Fund Managers Limited is authorised and regulated by the Financial Conduct Authority
The content of the information and materials on the Website and any other information and materials provided by or though CFM in connection with Co-Fund NI and associated investment opportunities and Investee Companies, including any financial promotion as defined in Financial Services and Markets as Act 2000(“FSMA”) constituted thereby, has not been approved by an authorised person within the meaning of FSMA. Reliance on the information provided in relation to any specific Investee Company or otherwise, including any financial promotion constituted thereby, for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

November 2023

Neurovalens Receive FDA Clearance for its Modius Sleep Device

ABOUT US

ADDITIONAL LINKS